How Pfizer optimized global working capital with SAP Taulia

Pfizer is one of the world’s leading pharmaceutical companies, operating at global scale across research, manufacturing, and distribution. As part of a broader digital transformation journey, Pfizer’s finance and procurement teams set out to modernize and consolidate their working capital programs, ensuring suppliers of all sizes could access early payment options while driving efficiency across the organization. Lynn DeHart, Vice President of Digital Finance Solutions and Transformation, leads this work alongside a diverse portfolio of financial systems and enterprise technology initiatives.

Before: Challenges and opportunities

Pfizer’s payables operations had grown across multiple programs and systems over time, creating fragmentation that limited efficiency and visibility. The company wanted to consolidate its disparate payables programs under a unified SAP-driven approach that would align with the broader technology strategy already in place across treasury and IT. Alongside this, Pfizer aimed to scale its early payment program, making working capital options available to a broader range of suppliers and unlocking further improvements in working capital performance across the organization.

Why SAP Taulia

SAP Taulia’s suite of solutions offered exactly the SAP-native approach Pfizer’s teams were looking for. Having collaborated with SAP Taulia for over a decade, Pfizer had a strong foundation of trust, consistent delivery, and proven performance to build on. The ability to consolidate Supply Chain Finance, Dynamic Discounting, and ERP-embedded virtual cards into a single solution aligned with Pfizer’s goal of simplifying its financial operations and boosting efficiency across procurement and finance. This continuity also meant Pfizer could move quickly, with a partner that understood its systems, processes, and goals.

After: Value-driven results

By scaling its early payment program through SAP Taulia Payables Finance, Pfizer exceeded its working capital targets, unlocking significant invoice value for suppliers and onboarding a large portion of its invited trade payables base within the first year. The program delivered competitive early payment terms to Pfizer’s supplier community while streamlining internal operations. For Lynn and her team, the partnership demonstrated that incremental improvements, when executed well, can deliver transformative working capital outcomes at scale, reinforcing Pfizer’s broader digital transformation strategy.